Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 104, pseudogene (RNU1-104P) is a human pseudogene belonging to the U1 small nuclear RNA (snRNA) multigene family[5][1]. Unlike functional genes, pseudogenes such as RNU1-104P contain mutations or structural changes that prevent them from encoding functional protein products. The RNU1-104P locus is transcribed, and recent evidence suggests that some U1 snRNA pseudogenes can produce variant snRNAs with regulatory potential, although their exact function remains unclear[2]. In general, snRNA pseudogenes are classified as non-coding RNA elements that may participate in the regulation of gene expression, but RNU1-104P itself is not recognized as a direct therapeutic target, and no drugs, disease biomarkers, or specific safety concerns have been reported for it[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 104, pseudogene (RNU1-104P).